🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Comparative trial of tolerability, reactogenicity, safety and immunogenicit...
Status
Completed
Location
LLC "Energiya zdorov'ya"
Start Date
2021-02-16
Trial ID
NCT05470582
Primary Objective: To evaluate for each influenza strain the non-inferiori...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00391391
The aim of this study is to evaluate the safety and immunogenicity of Fluzo...
Status
Completed
Location
Multiple Locations
Start Date
2013-09
Trial ID
NCT01946425
The purpose of this study is to evaluate the immunogenicity and safety of N...
Status
Completed
Location
Guzhen Center for Diseases Control and Prevention
Start Date
2013-12
Trial ID
NCT02269852
Treatments Being Tested
Influenza (flu) viruses change continuously, therefore also the parts of vi...
Status
Completed
Location
Site Reference ID/Investigator# 59243
Start Date
2009-06
Trial ID
NCT00881842
Treatments Being Tested
The purpose of this study is to evaluate the possibility that giving an inc...
Status
Completed
Location
Emory Children's Center - Pediatric Infectious Diseases
Start Date
2010-10
Trial ID
NCT01164553
Treatments Being Tested
This study is evaluating the safety and immunogenicity of GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-08-01
Trial ID
NCT00129129
Influenza virus is a significant pathogen in pediatric solid organ transpla...
Status
Recruiting
Location
Stanford University
Start Date
2024-09-26
Trial ID
NCT05947071
This study is a randomized immunogenicity study in an enrolled cohort with ...
Status
Completed
Location
Valleywise Health Comprehensive Health Center
Start Date
2024-09-09
Trial ID
NCT06518577
Treatments Being Tested
The aim of the study was to assess the immunogenicity and safety of Fluzone...
Status
Completed
Location
Sanofi Pasteur Investigational Site 002
Start Date
2015-06-17
Trial ID
NCT03546192
Treatments Being Tested